Adele M. Gulfo - 29 Jan 2025 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
29 Jan 2025
Net transactions value
$0
Form type
4
Filing time
31 Jan 2025, 16:10:03 UTC
Previous filing
19 Dec 2024
Next filing
13 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Common Stock (Right to Buy) Award $0 +37,200 $0.000000 37,200 29 Jan 2025 Common Stock 37,200 $14.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares of common stock subject to the option vest monthly following January 29, 2025, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date.